InvestorsHub Logo
Followers 0
Posts 335
Boards Moderated 0
Alias Born 06/02/2004

Re: silver bullet post# 11275

Tuesday, 11/09/2010 7:09:19 AM

Tuesday, November 09, 2010 7:09:19 AM

Post# of 12383
From the PI report.

3307 A Phase I Study of ENMD-2076 In Patients with Relapsed or Refractory Leukemia
The recommended phase two dose (RPTD) is 225 mg/day.


I thought all of the patients were reduced to 275mg/day.
There’s surely more to this story as well.